Kindred Biosciences, Inc.

KIN

Delisted

KIN was delisted on the 27th of August, 2021.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	BG 1 Baupost Group Boston, Massachusetts	$32.4M	+$34.6M	+2,900,000	New
2	2 Adage Capital Partners Boston, Massachusetts	$14.8M	+$15.7M	+1,321,372	New
3	3 Fidelity Investments Boston, Massachusetts	$12.3M	+$13.1M	+1,100,000	New
4	4 Jennison Associates New York	$10M	+$10.7M	+901,774	New
5	KCM 5 Kingdon Capital Management New York	$6.68M	+$7.15M	+600,000	New
6	6 Franklin Resources San Mateo, California	$3.37M	+$3.61M	+302,800	New
7	DM 7 Deerfield Management New York	$2.51M	+$2.68M	+225,000	New
8	AWMDMG 8 Austin W. Marxe & David M. Greenhouse New York	$2.23M	+$2.38M	+200,000	New
9	PI 9 Putnam Investments Boston, Massachusetts	$1.67M	+$1.79M	+150,000	New
10	TG 10 TCW Group Los Angeles, California	$1.61M	+$1.72M	+144,699	New
11	DCM 11 Driehaus Capital Management Chicago, Illinois	$1.58M	+$1.69M	+141,519	New
12	FCM 12 Farallon Capital Management San Francisco, California	$918K	+$983K	+82,445	New
13	BI 13 BVF Inc San Francisco, California	$577K	+$617K	+51,788	New
14	HVC 14 Healthcare Value Capital Woodcliff Lake, New Jersey	$559K	+$596K	+50,000	New
15	HHC 15 Hutchin Hill Capital New York	$131K	+$140K	+11,719	New
16	CCA 16 Catalyst Capital Advisors Huntington, New York	$111K	+$119K	+10,000	New
17	TRCT 17 Tower Research Capital (TRC) New York	$55K	+$58.6K	+4,918	New
18	U 18 UBS Zurich, Switzerland	$14K	+$15.4K	+1,291	New
19	19 Morgan Stanley New York	$6K	+$5.96K	+500	New
20	20 Citigroup New York	$1K	+$1K	+84	New